Global Bronchiectasis Treatment Drug Market Growth (Status and Outlook) 2025-2031

March 2025 | 119 pages | ID: GC8F914F3D4FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Bronchiectasis Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Bronchiectasis Treatment Drug Industry Forecast” looks at past sales and reviews total world Bronchiectasis Treatment Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Bronchiectasis Treatment Drug sales for 2025 through 2031. With Bronchiectasis Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bronchiectasis Treatment Drug industry.

This Insight Report provides a comprehensive analysis of the global Bronchiectasis Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bronchiectasis Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bronchiectasis Treatment Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bronchiectasis Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bronchiectasis Treatment Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Bronchiectasis Treatment Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Amikacin Sulfate
• ARD-3150
• CHF-6333
• Ciprofloxacin Hydrochloride
• Doxofylline
• Others

Segmentation by Application:

• Offline Pharmacy
• Online Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Grifols
• GlaxoSmithKline
• Sanofi
• Boehringer-Ingelheim
• Cadilapharma
• Aradigm Corporation
• Zambon
• Santhera Pharmaceuticals
• Bayer
• Insmed Inc
• Alitair Pharmaceuticals
• Polyphor
• Kamada Ltd

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bronchiectasis Treatment Drug Market Size (2020-2031)
  2.1.2 Bronchiectasis Treatment Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Bronchiectasis Treatment Drug by Country/Region (2020, 2024 & 2031)
2.2 Bronchiectasis Treatment Drug Segment by Type
  2.2.1 Amikacin Sulfate
  2.2.2 ARD-3150
  2.2.3 CHF-6333
  2.2.4 Ciprofloxacin Hydrochloride
  2.2.5 Doxofylline
  2.2.6 Others
2.3 Bronchiectasis Treatment Drug Market Size by Type
  2.3.1 Bronchiectasis Treatment Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Bronchiectasis Treatment Drug Market Size Market Share by Type (2020-2025)
2.4 Bronchiectasis Treatment Drug Segment by Application
  2.4.1 Offline Pharmacy
  2.4.2 Online Pharmacy
2.5 Bronchiectasis Treatment Drug Market Size by Application
  2.5.1 Bronchiectasis Treatment Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Bronchiectasis Treatment Drug Market Size Market Share by Application (2020-2025)

3 BRONCHIECTASIS TREATMENT DRUG MARKET SIZE BY PLAYER

3.1 Bronchiectasis Treatment Drug Market Size Market Share by Player
  3.1.1 Global Bronchiectasis Treatment Drug Revenue by Player (2020-2025)
  3.1.2 Global Bronchiectasis Treatment Drug Revenue Market Share by Player (2020-2025)
3.2 Global Bronchiectasis Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BRONCHIECTASIS TREATMENT DRUG BY REGION

4.1 Bronchiectasis Treatment Drug Market Size by Region (2020-2025)
4.2 Global Bronchiectasis Treatment Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bronchiectasis Treatment Drug Market Size Growth (2020-2025)
4.4 APAC Bronchiectasis Treatment Drug Market Size Growth (2020-2025)
4.5 Europe Bronchiectasis Treatment Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Bronchiectasis Treatment Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
5.2 Americas Bronchiectasis Treatment Drug Market Size by Type (2020-2025)
5.3 Americas Bronchiectasis Treatment Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bronchiectasis Treatment Drug Market Size by Region (2020-2025)
6.2 APAC Bronchiectasis Treatment Drug Market Size by Type (2020-2025)
6.3 APAC Bronchiectasis Treatment Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025)
7.2 Europe Bronchiectasis Treatment Drug Market Size by Type (2020-2025)
7.3 Europe Bronchiectasis Treatment Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bronchiectasis Treatment Drug by Region (2020-2025)
8.2 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BRONCHIECTASIS TREATMENT DRUG MARKET FORECAST

10.1 Global Bronchiectasis Treatment Drug Forecast by Region (2026-2031)
  10.1.1 Global Bronchiectasis Treatment Drug Forecast by Region (2026-2031)
  10.1.2 Americas Bronchiectasis Treatment Drug Forecast
  10.1.3 APAC Bronchiectasis Treatment Drug Forecast
  10.1.4 Europe Bronchiectasis Treatment Drug Forecast
  10.1.5 Middle East & Africa Bronchiectasis Treatment Drug Forecast
10.2 Americas Bronchiectasis Treatment Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Bronchiectasis Treatment Drug Forecast
  10.2.2 Canada Market Bronchiectasis Treatment Drug Forecast
  10.2.3 Mexico Market Bronchiectasis Treatment Drug Forecast
  10.2.4 Brazil Market Bronchiectasis Treatment Drug Forecast
10.3 APAC Bronchiectasis Treatment Drug Forecast by Region (2026-2031)
  10.3.1 China Bronchiectasis Treatment Drug Market Forecast
  10.3.2 Japan Market Bronchiectasis Treatment Drug Forecast
  10.3.3 Korea Market Bronchiectasis Treatment Drug Forecast
  10.3.4 Southeast Asia Market Bronchiectasis Treatment Drug Forecast
  10.3.5 India Market Bronchiectasis Treatment Drug Forecast
  10.3.6 Australia Market Bronchiectasis Treatment Drug Forecast
10.4 Europe Bronchiectasis Treatment Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Bronchiectasis Treatment Drug Forecast
  10.4.2 France Market Bronchiectasis Treatment Drug Forecast
  10.4.3 UK Market Bronchiectasis Treatment Drug Forecast
  10.4.4 Italy Market Bronchiectasis Treatment Drug Forecast
  10.4.5 Russia Market Bronchiectasis Treatment Drug Forecast
10.5 Middle East & Africa Bronchiectasis Treatment Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Bronchiectasis Treatment Drug Forecast
  10.5.2 South Africa Market Bronchiectasis Treatment Drug Forecast
  10.5.3 Israel Market Bronchiectasis Treatment Drug Forecast
  10.5.4 Turkey Market Bronchiectasis Treatment Drug Forecast
10.6 Global Bronchiectasis Treatment Drug Forecast by Type (2026-2031)
10.7 Global Bronchiectasis Treatment Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Bronchiectasis Treatment Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Grifols
  11.1.1 Grifols Company Information
  11.1.2 Grifols Bronchiectasis Treatment Drug Product Offered
  11.1.3 Grifols Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Grifols Main Business Overview
  11.1.5 Grifols Latest Developments
11.2 GlaxoSmithKline
  11.2.1 GlaxoSmithKline Company Information
  11.2.2 GlaxoSmithKline Bronchiectasis Treatment Drug Product Offered
  11.2.3 GlaxoSmithKline Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GlaxoSmithKline Main Business Overview
  11.2.5 GlaxoSmithKline Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Bronchiectasis Treatment Drug Product Offered
  11.3.3 Sanofi Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments
11.4 Boehringer-Ingelheim
  11.4.1 Boehringer-Ingelheim Company Information
  11.4.2 Boehringer-Ingelheim Bronchiectasis Treatment Drug Product Offered
  11.4.3 Boehringer-Ingelheim Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Boehringer-Ingelheim Main Business Overview
  11.4.5 Boehringer-Ingelheim Latest Developments
11.5 Cadilapharma
  11.5.1 Cadilapharma Company Information
  11.5.2 Cadilapharma Bronchiectasis Treatment Drug Product Offered
  11.5.3 Cadilapharma Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Cadilapharma Main Business Overview
  11.5.5 Cadilapharma Latest Developments
11.6 Aradigm Corporation
  11.6.1 Aradigm Corporation Company Information
  11.6.2 Aradigm Corporation Bronchiectasis Treatment Drug Product Offered
  11.6.3 Aradigm Corporation Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Aradigm Corporation Main Business Overview
  11.6.5 Aradigm Corporation Latest Developments
11.7 Zambon
  11.7.1 Zambon Company Information
  11.7.2 Zambon Bronchiectasis Treatment Drug Product Offered
  11.7.3 Zambon Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Zambon Main Business Overview
  11.7.5 Zambon Latest Developments
11.8 Santhera Pharmaceuticals
  11.8.1 Santhera Pharmaceuticals Company Information
  11.8.2 Santhera Pharmaceuticals Bronchiectasis Treatment Drug Product Offered
  11.8.3 Santhera Pharmaceuticals Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Santhera Pharmaceuticals Main Business Overview
  11.8.5 Santhera Pharmaceuticals Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer Bronchiectasis Treatment Drug Product Offered
  11.9.3 Bayer Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 Insmed Inc
  11.10.1 Insmed Inc Company Information
  11.10.2 Insmed Inc Bronchiectasis Treatment Drug Product Offered
  11.10.3 Insmed Inc Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Insmed Inc Main Business Overview
  11.10.5 Insmed Inc Latest Developments
11.11 Alitair Pharmaceuticals
  11.11.1 Alitair Pharmaceuticals Company Information
  11.11.2 Alitair Pharmaceuticals Bronchiectasis Treatment Drug Product Offered
  11.11.3 Alitair Pharmaceuticals Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Alitair Pharmaceuticals Main Business Overview
  11.11.5 Alitair Pharmaceuticals Latest Developments
11.12 Polyphor
  11.12.1 Polyphor Company Information
  11.12.2 Polyphor Bronchiectasis Treatment Drug Product Offered
  11.12.3 Polyphor Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Polyphor Main Business Overview
  11.12.5 Polyphor Latest Developments
11.13 Kamada Ltd
  11.13.1 Kamada Ltd Company Information
  11.13.2 Kamada Ltd Bronchiectasis Treatment Drug Product Offered
  11.13.3 Kamada Ltd Bronchiectasis Treatment Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Kamada Ltd Main Business Overview
  11.13.5 Kamada Ltd Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bronchiectasis Treatment Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Bronchiectasis Treatment Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Amikacin Sulfate
Table 4. Major Players of ARD-3150
Table 5. Major Players of CHF-6333
Table 6. Major Players of Ciprofloxacin Hydrochloride
Table 7. Major Players of Doxofylline
Table 8. Major Players of Others
Table 9. Bronchiectasis Treatment Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Bronchiectasis Treatment Drug Market Size Market Share by Type (2020-2025)
Table 12. Bronchiectasis Treatment Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Bronchiectasis Treatment Drug Market Size Market Share by Application (2020-2025)
Table 15. Global Bronchiectasis Treatment Drug Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Bronchiectasis Treatment Drug Revenue Market Share by Player (2020-2025)
Table 17. Bronchiectasis Treatment Drug Key Players Head office and Products Offered
Table 18. Bronchiectasis Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Bronchiectasis Treatment Drug Market Size Market Share by Region (2020-2025)
Table 23. Global Bronchiectasis Treatment Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Bronchiectasis Treatment Drug Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Bronchiectasis Treatment Drug Market Size Market Share by Country (2020-2025)
Table 27. Americas Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Bronchiectasis Treatment Drug Market Size Market Share by Type (2020-2025)
Table 29. Americas Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Bronchiectasis Treatment Drug Market Size Market Share by Application (2020-2025)
Table 31. APAC Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Bronchiectasis Treatment Drug Market Size Market Share by Region (2020-2025)
Table 33. APAC Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Bronchiectasis Treatment Drug Market Size Market Share by Country (2020-2025)
Table 37. Europe Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Bronchiectasis Treatment Drug
Table 43. Key Market Challenges & Risks of Bronchiectasis Treatment Drug
Table 44. Key Industry Trends of Bronchiectasis Treatment Drug
Table 45. Global Bronchiectasis Treatment Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Bronchiectasis Treatment Drug Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Bronchiectasis Treatment Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Bronchiectasis Treatment Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Grifols Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 50. Grifols Bronchiectasis Treatment Drug Product Offered
Table 51. Grifols Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Grifols Main Business
Table 53. Grifols Latest Developments
Table 54. GlaxoSmithKline Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 55. GlaxoSmithKline Bronchiectasis Treatment Drug Product Offered
Table 56. GlaxoSmithKline Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. GlaxoSmithKline Main Business
Table 58. GlaxoSmithKline Latest Developments
Table 59. Sanofi Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 60. Sanofi Bronchiectasis Treatment Drug Product Offered
Table 61. Sanofi Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Sanofi Main Business
Table 63. Sanofi Latest Developments
Table 64. Boehringer-Ingelheim Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 65. Boehringer-Ingelheim Bronchiectasis Treatment Drug Product Offered
Table 66. Boehringer-Ingelheim Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Boehringer-Ingelheim Main Business
Table 68. Boehringer-Ingelheim Latest Developments
Table 69. Cadilapharma Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 70. Cadilapharma Bronchiectasis Treatment Drug Product Offered
Table 71. Cadilapharma Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Cadilapharma Main Business
Table 73. Cadilapharma Latest Developments
Table 74. Aradigm Corporation Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 75. Aradigm Corporation Bronchiectasis Treatment Drug Product Offered
Table 76. Aradigm Corporation Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Aradigm Corporation Main Business
Table 78. Aradigm Corporation Latest Developments
Table 79. Zambon Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 80. Zambon Bronchiectasis Treatment Drug Product Offered
Table 81. Zambon Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Zambon Main Business
Table 83. Zambon Latest Developments
Table 84. Santhera Pharmaceuticals Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 85. Santhera Pharmaceuticals Bronchiectasis Treatment Drug Product Offered
Table 86. Santhera Pharmaceuticals Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Santhera Pharmaceuticals Main Business
Table 88. Santhera Pharmaceuticals Latest Developments
Table 89. Bayer Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 90. Bayer Bronchiectasis Treatment Drug Product Offered
Table 91. Bayer Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Bayer Main Business
Table 93. Bayer Latest Developments
Table 94. Insmed Inc Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 95. Insmed Inc Bronchiectasis Treatment Drug Product Offered
Table 96. Insmed Inc Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Insmed Inc Main Business
Table 98. Insmed Inc Latest Developments
Table 99. Alitair Pharmaceuticals Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 100. Alitair Pharmaceuticals Bronchiectasis Treatment Drug Product Offered
Table 101. Alitair Pharmaceuticals Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Alitair Pharmaceuticals Main Business
Table 103. Alitair Pharmaceuticals Latest Developments
Table 104. Polyphor Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 105. Polyphor Bronchiectasis Treatment Drug Product Offered
Table 106. Polyphor Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Polyphor Main Business
Table 108. Polyphor Latest Developments
Table 109. Kamada Ltd Details, Company Type, Bronchiectasis Treatment Drug Area Served and Its Competitors
Table 110. Kamada Ltd Bronchiectasis Treatment Drug Product Offered
Table 111. Kamada Ltd Bronchiectasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Kamada Ltd Main Business
Table 113. Kamada Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Bronchiectasis Treatment Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bronchiectasis Treatment Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Bronchiectasis Treatment Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Bronchiectasis Treatment Drug Sales Market Share by Country/Region (2024)
Figure 8. Bronchiectasis Treatment Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Bronchiectasis Treatment Drug Market Size Market Share by Type in 2024
Figure 10. Bronchiectasis Treatment Drug in Offline Pharmacy
Figure 11. Global Bronchiectasis Treatment Drug Market: Offline Pharmacy (2020-2025) & ($ millions)
Figure 12. Bronchiectasis Treatment Drug in Online Pharmacy
Figure 13. Global Bronchiectasis Treatment Drug Market: Online Pharmacy (2020-2025) & ($ millions)
Figure 14. Global Bronchiectasis Treatment Drug Market Size Market Share by Application in 2024
Figure 15. Global Bronchiectasis Treatment Drug Revenue Market Share by Player in 2024
Figure 16. Global Bronchiectasis Treatment Drug Market Size Market Share by Region (2020-2025)
Figure 17. Americas Bronchiectasis Treatment Drug Market Size 2020-2025 ($ millions)
Figure 18. APAC Bronchiectasis Treatment Drug Market Size 2020-2025 ($ millions)
Figure 19. Europe Bronchiectasis Treatment Drug Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Bronchiectasis Treatment Drug Market Size 2020-2025 ($ millions)
Figure 21. Americas Bronchiectasis Treatment Drug Value Market Share by Country in 2024
Figure 22. United States Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Bronchiectasis Treatment Drug Market Size Market Share by Region in 2024
Figure 27. APAC Bronchiectasis Treatment Drug Market Size Market Share by Type (2020-2025)
Figure 28. APAC Bronchiectasis Treatment Drug Market Size Market Share by Application (2020-2025)
Figure 29. China Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. India Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Bronchiectasis Treatment Drug Market Size Market Share by Country in 2024
Figure 36. Europe Bronchiectasis Treatment Drug Market Size Market Share by Type (2020-2025)
Figure 37. Europe Bronchiectasis Treatment Drug Market Size Market Share by Application (2020-2025)
Figure 38. Germany Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 39. France Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Bronchiectasis Treatment Drug Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Bronchiectasis Treatment Drug Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Bronchiectasis Treatment Drug Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Bronchiectasis Treatment Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 52. APAC Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 53. Europe Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 55. United States Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 56. Canada Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 57. Mexico Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 58. Brazil Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 59. China Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 60. Japan Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 61. Korea Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 63. India Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 64. Australia Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 65. Germany Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 66. France Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 67. UK Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 68. Italy Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 69. Russia Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 70. Egypt Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 71. South Africa Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 72. Israel Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 73. Turkey Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)
Figure 74. Global Bronchiectasis Treatment Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Bronchiectasis Treatment Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Bronchiectasis Treatment Drug Market Size 2026-2031 ($ millions)